Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) EPS (Basic) (2024 - 2025)

Historic EPS (Basic) for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$0.08.

  • Kairos Pharma's EPS (Basic) fell 30000.0% to -$0.08 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.34, marking a year-over-year change of. This contributed to the annual value of -$0.27 for FY2024, which is 5606.57% down from last year.
  • Latest data reveals that Kairos Pharma reported EPS (Basic) of -$0.08 as of Q2 2025, which was down 30000.0% from -$0.08 recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's EPS (Basic) ranged from a high of -$0.02 in Q2 2024 and a low of -$0.14 during Q4 2024